Get the Stockscreener App
10.29
0.10%
0.010
Helix Acquisition Corp Iii stock is traded at $10.29, with a volume of 650.
It is up +0.10% in the last 24 hours and up +0.88% over the past month.
Helix Acquisition Corp III is a blank check company.
See More
Previous Close:
$10.28
Open:
$10.17
24h Volume:
650
Relative Volume:
0.03
Market Cap:
$221.21M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-0.10%
1M Performance:
+0.88%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$10.17
$10.30
1-Week Range:
$10.14
$10.33
52-Week Range:
$10.13
$10.35
Helix Acquisition Corp Iii Stock (HLXC) Company Profile
Name
Helix Acquisition Corp Iii
Sector
Industry
Phone
-
Address
-
Compare HLXC vs CCXI, LION, XXI, DMII, BCSS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HLXC
Helix Acquisition Corp Iii
|
10.29 | 220.99M | 0 | 0 | 0 | 0.00 |
|
CCXI
Churchill Capital Corp Xi
|
10.11 | 3.64B | 0 | 0 | 0 | 0.00 |
|
LION
Lionsgate Studios Corp
|
9.43 | 2.63B | 3.13B | -174.20M | -111.20M | -0.6937 |
|
XXI
Twenty One Capital Inc
|
6.69 | 2.14B | 0 | 0 | 0 | 0.00 |
|
DMII
Drugs Made In America Acquisition Ii Corp
|
9.97 | 653.78M | 0 | 0 | 0 | 0.00 |
|
BCSS
Bain Capital Gss Investment Corp
|
10.20 | 593.34M | 0 | 0 | 0 | 0.00 |
Helix Acquisition Corp Iii Stock (HLXC) Latest News
HLXB Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
HLXC Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
HLXB SEC FilingsHelix Acqsn II 10-K, 10-Q, 8-K Forms - Stock Titan
Published on: 2026-02-25 06:31:57 - baoquankhu1.vn
Is Helix Acquisition Corp II being accumulated by smart money2025 Year in Review & Growth Focused Entry Reports - baoquankhu1.vn
3,125,000 Class B Ordinary Shares of Helix Acquisition Corp. III are subject to a Lock-Up Agreement Ending on 22-FEB-2026. - marketscreener.com
Whale Trades: Is MYPSW in a consolidation phaseJuly 2025 Setups & Reliable Intraday Trade Alerts - baoquankhu1.vn
HLXC Should I Buy - Intellectia AI
What Wall Street predicts for Plutonian Acquisition Corp. Equity Warrant stock price2025 Sector Review & Safe Capital Growth Trade Ideas - mfd.ru
Will Anixa Biosciences Inc. stock reach all time highs in 2025Weekly Risk Report & Breakout Confirmation Trade Signals - mfd.ru
A | Is Helix Acquisition Corp. II on track to beat earningsMarket Activity Recap & Capital Efficient Trading Techniques - mfd.ru
Aug Opening: Is ONCO being accumulated by smart moneyQuarterly Earnings Report & Community Verified Swing Trade Signals - baoquankhu1.vn
Can AIFER ride the EV waveQuarterly Profit Review & Free Long-Term Investment Growth Plans - mfd.ru
How Helix Acquisition Corp. II stock reacts to job market dataMarket Risk Report & Stepwise Entry and Exit Trade Signals - mfd.ru
Why Is Helix Acquisition Corp. III Class A Ordinary Shares (HLXC) Stock Down Today? - Meyka
Newsroom - White & Case LLP
Helix Acquisition Corp. III completes $172.5 million IPO and private placement - Investing.com Nigeria
Helix Acquisition Corp. III Completes Initial Public Offering - TradingView
Finance Watch: SPACs Attempt A Comeback As IPO Market Shows Signs Of Life - Citeline News & Insights
Does Helix Acquisition Corp. II have strong fundamentalsJuly 2025 Macro Moves & Advanced Technical Analysis Signals - mfd.ru
With a Thin IPO Calendar, Hedge Funds Are Zeroing In on Biopharma - Institutional Investor
Helix Acquisition prices $150M initial public offering - MSN
Will Helix Acquisition Corp. II stock continue dividend increasesRate Cut & AI Forecast Swing Trade Picks - mfd.ru
Helix Acquisition Corp. III raises $172.5 million in Nasdaq IPO By Investing.com - Investing.com Nigeria
Helix Acquisition Corp III closes $172.5 million IPO By Investing.com - Investing.com South Africa
Helix Acquisition Corp. III closes $172.5 million IPO By Investing.com - Investing.com Australia
Helix Acquisition Corp. III raises $172.5 million in Nasdaq IPO - Investing.com
Helix Acquisition Corp. III closes $172.5 million IPO - Investing.com India
Helix Acquisition Corp. III Announces Closing of $172.5 Million Initial Public Offering, Including the Full Exercise of the Underwriter's Option to Purchase Additional Shares - The Manila Times
SL Green Realty Corp. Announces Date of 2026 Annual Meeting of Stockholders - The Manila Times
Helix Acquisition Corp III closes $172.5 million IPO - Investing.com
White & Case advises Helix Acquisition Corp. III on upsized US$150 million IPO - White & Case LLP
Biotech investor Cormorant secures $150M for another SPAC deal - BioPharma Dive
Return on equity % of Helix Acquisition Corp. III – NASDAQ:HLXC - TradingView
Insider Buy: Does Unusual Machines Inc align with a passive investing strategyTrade Entry Report & Low Risk Investment Opportunities - baoquankhu1.vn
Helix Acquisition III Raises $150 Million, Targets Healthcare Sector - intellectia.ai
Helix Acquisition Corp. III Prices Upsized $150 Mln IPO - Nasdaq
Helix Acquisition Corp. III Announces Pricing of Upsized $150 Million Initial Public Offering - The Manila Times
U.S. IPO Weekly Recap: Equipment Rental Rises While Crypto Company Crashes In 2-IPO Week - Seeking Alpha
symbol__ Stock Quote Price and Forecast - CNN
Day One was one of three parties interested in Mersana; Bihua Chen and Cormorant’s third SPAC - Endpoints News
HLXC IPO NewsCormorant's SPAC Helix Acquisition III files for a $125 million IPO, targeting healthcare - renaissancecapital.com
BBOT Reports Third Quarter 2025 Financial Results and Update on Corporate Progress - GlobeNewswire
BridgeBio Oncology stock initiated with Outperform rating at Oppenheimer - Investing.com
SPACs Line Up To Clear Biotech’s IPO Backlog - BioSpace
Helix Acquisition Corp. II Completes Merger with BridgeBio - The Globe and Mail
Cantor Fitzgerald initiates BridgeBio Oncology stock with Overweight rating By Investing.com - Investing.com Nigeria
BridgeBio Oncology Therapeutics (Helix Acquisition II): BBOT IPO, SPACBlank check company formed by Cormorant Asset Management targeting healthcare (completed 8/11/2025). - renaissancecapital.com
BBOTBridgeBio Oncology Therapeutics, Inc Latest Stock News & Market Updates - Stock Titan
BridgeBio Oncology Lands Massive $382M SPAC Deal as Top Investors Back Cancer Drug Pipeline - Stock Titan
BBOT Appoints Industry Veteran Uneek Mehra as Chief Financial Officer - Business Wire
Helix Acquisition Corp Iii Stock (HLXC) Financials Data
There is no financial data for Helix Acquisition Corp Iii (HLXC). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.00%
0.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):